## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.7% in lower entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (2.9%) confirms momentum alignment. Strong momentum (+3.9% 5-day acceleration). Outperforming sector by 4.4%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($153.23)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Morgan Stanley Hikes Lam Research (LRCX) PT to $158, Keeps Equal Weight on Increased 2027 Wafer Fab Equipment Forecast**
- Source: Insider Monkey | 20251208T060836 | Somewhat-Bullish | Relevance: 98%
-  Morgan Stanley analyst Shane Brett increased the price target for Lam Research (LRCX) to $158 while maintaining an Equal Weight rating, citing an increased 2027 Wafer Fab Equipment (WFE) forecast. The company reported strong Q1 2026 revenues of $5.32 billion and provided optimistic guidance for Q2 2026, projecting ~$5.2 billion revenues. Despite the positive outlook, the article suggests that other AI stocks might offer greater return potential.

**2. Investment Management Corp of Ontario Increases Stock Position in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T141418 | Somewhat-Bullish | Relevance: 98%
-  Investment Management Corp of Ontario significantly increased its stake in Lam Research Corporation by 90.3% in the second quarter, now owning 108,638 shares valued at $10.575 million. Other institutional investors also adjusted their positions in the semiconductor company. Insider activity and analyst ratings are also detailed, with analysts giving Lam Research an average rating of "Moderate Buy" and a consensus target price of $152.87.

**3. Lam Research Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251209T163400 | Bullish | Relevance: 98%
- Shares of Lam Research Corp. (LRCX) rose 1.89% to $165.81 on Tuesday, outperforming the broader market which saw declines for both the S&P 500 Index and the Dow Jones Industrial Average. This marks the third consecutive day of gains for the stock.

**4. Morgan Stanley Hikes Lam Research (LRCX) PT to $158, Keeps Equal Weight on Increased 2027 Wafer Fab Equipment Forecast**
- Source: Insider Monkey | 20251208T060909 | Bullish | Relevance: 98%
-  Morgan Stanley analyst Shane Brett raised the firm's price target on Lam Research (LRCX) to $158 from $137, while maintaining an "Equal Weight" rating. This adjustment follows the firm's decision to largely keep its 2026 Wafer Fab Equipment (WFE) forecast and increase its 2027 WFE forecast to $145 billion, signifying a 13% rise. The article also highlights Lam Research's strong FQ1 2026 revenues and positive FQ2 2026 guidance.

**5. SVB Wealth LLC Acquires Shares of 28,255 Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T124742 | Somewhat-Bullish | Relevance: 98%
-  SVB Wealth LLC has acquired 28,255 shares of Lam Research Corporation, valued at approximately $2.75 million, establishing a new position in the semiconductor company. This comes as other institutional investors have also adjusted their holdings, with institutional ownership now standing at around 84.61%. Despite recent insider selling, Lam Research reported a strong quarterly performance, exceeding EPS and revenue expectations, and analysts currently rate the stock as a "Moderate Buy" with an average target price of $152.87.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 6 ($14.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $14M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_20 improving +3.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.39 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $209.1B |
| Beta | 1.78 |
| 52W Range | $56.32 - $167.15 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.39 |
| Forward P/E | 29.7 |
| Current P/E | 34.3 |
| YoY Growth | 15.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 1.8% to 5.7% (+3.9% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 2.9% confirms short-term momentum alignment. AM_20 at 7.9% shows strong absolute momentum above own 20MA. Outperforming sector by 4.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.00), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.65% (CS: 87) | Strong |
| RSI_14 | 62.7 | Neutral |
| MACD Histogram | 1.00 | Bullish |
| vs SMA20 | 1.079x | Above |
| vs SMA50 | 1.099x | Above |
| vs SMA200 | 1.577x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $165.81
- **Stop Loss:** $153.23 (7.6% risk)
- **Target:** $184.68 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 95
- **Position Value:** $15,751.95
- **Portfolio %:** 15.75%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*